Parkinson's disease

Indication for Levodopa

Population group: Suitable for both men and women, only adults (18 years old or older)

Levodopa is indicated for the intermittent treatment of OFF episodes in patients with Parkinson’s disease treated with carbidopa/levodopa.

For this indication, competent medicine agencies globally authorize below treatments:

84-420 mg in 1-5 divided doses daily

Route of admnistration

Respiratory (Inhalation)

Defined daily dose

84 - 420 mg

Dosage regimen

From 16.8 To 84 mg 5 time(s) per day every day

Detailed description

Levodopa should be taken when symptoms of an OFF period start to return.

The recommended dosage of levodopa is oral inhalation of the contents of two 42 mg capsules (84 mg) as needed, up to 5 times a day. The maximum dose per OFF period is 84 mg, and the maximum daily dosage is 420 mg. Levodopa has been shown to be effective only in combination with carbidopa/levodopa.

Active ingredient

According to the current understanding, the symptoms of Parkinson’s disease are related to depletion of dopamine in the corpus striatum. Dopamine does not cross the blood-brain barrier. Levodopa, the precursor of dopamine, crosses the blood brain barrier and relieves the symptoms of the disease.

Read more about Levodopa

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner